Clinical Trial

Clinical Relevance of the HD sEMG Signals in the Post-stroke Rehabilitation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2024 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn about the WPM-SEMG-V2 device (Wireless Portable and Multi-Channel, WPM) designated to acquire high-density (HD) surface electromyography (sEMG) signals in healthy volunteers and post-stroke patients. The main objectives are: 1) to technically and clinically validate the WPM-SEMG-V2 device in healthy volunteers; 2) to demonstrate the clinical relevance of the HD sEMG signals to support the process of rehabilitation of post-stroke patients. Participants will be asked to perform simple exercises using the muscles of the hand or the leg in static or dynamic contractions while wearing the WPM-SEMG-V2 device.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-04-28; most recent amendment 2024-09-02.
Status change: Not Yet Recruiting → Recruiting 2024-01-11
Trial Details
NCT Number NCT05849896
Lead Sponsor Alain Kaelin
Collaborators: University of Applied Sciences and Arts of Southern Switzerland, Clinical Trial Unit Ente Ospedaliero Cantonale
Conditions Stroke
Enrollment 40 participants
Start Date 2023-03-13
Primary Completion 2026-02 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2024-09-05